Skip to main content
OpenTrials

Clinical trial condition

Herpes Zoster

Explore clinical trials studying Herpes Zoster. Study availability and eligibility vary by location and protocol.

174 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Herpes Zoster trial results

Completed

The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept

NCT03604406

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +14 more
Locations
  • St. Luke's Health System Boise, Idaho, United States
  • St. Paul Rheumatology Eagan, Minnesota, United States
  • Jayashree Sinha, MD Clovis, New Mexico, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults

NCT02723773

Conditions
DNA Virus Infections, Herpes Zoster, Herpes Zoster Vaccine, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 161 locations
View Trial Details
Completed

A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response

NCT04176939

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Brussels, Belgium
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Helsinki, Finland
View all 15 locations
View Trial Details
Completed

A Study on the Immune Response and Safety of a Vaccine Against Herpes Zoster in Adults Aged 50 Years and Older in India

NCT05219253

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Visakhapatnam, Andhra Pradesh, India
  • GSK Investigational Site North Guwāhāti, Assam, India
  • GSK Investigational Site Ahmedabad, Gujarat, India
  • GSK Investigational Site Mumbai, Maharashtra, India
View Trial Details
Completed

Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years

NCT04869982

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Huaian, Jiangsu, China
  • GSK Investigational Site Lianyungang, China
  • GSK Investigational Site Shanghai, China
  • GSK Investigational Site Shanghai, China
View Trial Details

Related conditions